ArticleAmerican journal of cancer research2019

Overexpression of MEF2D contributes to oncogenic malignancy and chemotherapeutic resistance in ovarian carcinoma.

Xiaoxue Li et al.PubMed ↗Full text ↗

No numbers read from the abstract.